West Pharmaceutical Services Contract-Manufactured Products — Goodwill increased by 2.4% to $29.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $29.20M to $29.90M.
An increase suggests recent acquisitions, while a decrease indicates potential impairment charges reflecting reduced expectations for future segment earnings.
Represents the intangible asset value recorded when the contract-manufactured products business unit was acquired for a...
Commonly reported as 'Goodwill' under segment assets for companies with acquisitive growth strategies in manufacturing.
wst_segment_contract_manufactured_products_goodwill| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $29.80M | $29.40M | $29.60M | $29.20M | $29.90M |
| QoQ Change | — | -1.3% | +0.7% | -1.4% | +2.4% |
| YoY Change | — | -1.3% | +0.7% | -1.4% | +2.4% |